JPRN-UMIN000033746已完成未知
Clinical trials of the safety and efficacy of strain sensors for cough - Review of cough monitor
Kobe University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2018年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •<First stage> 1. Subjects judged inappropriate by the person in charge of this study <Second stage> 1. An unstable person who developed cardiovascular disease within 3 months 2. Persons who have serious illness such as advanced cancer and have a life expectancy of less than 6 months 3. Case of PS3/4 4. Persons with active infections that require treatment 5. Wounds at wearing site 6. Skin disorder (psoriasis) requiring treatment at the site of attachment 7. Subjects judged inappropriate by the person in charge of this study
研究者
相似试验
招募中
2 期
Clinical trial to verify safety and efficacy of Stemirac that does not meet in-process control specifications and shipping specifications for acute traumatic spinal cord injury patients.JPRN-jRCT2013210056Tomii Ryo10
尚未招募
1 期
Phase I clinical trial to examine the safety of stereotactic radiotherapy including subclinical regions for pancreatic cancerPancreatic cancerJPRN-UMIN000044754Tohoku University18
招募中
不适用
Clinical trials for the safety and efficacy of the combination of XELOX,the colorectal cancer radical resection adjuvant chemotherapy and of chronic hepatitis therapeutic agent 3 oxygelmillpropionic acid polymer.(Phase 1 test)Colorectal cancerJPRN-UMIN000022440Osaka University Hospital5
已完成
2 期
effect of Sovodak in patients with hepatitis C and HIV-1Condition 1: Hepatitis C and HIV. Condition 2: Human immunodeficiency virus.Acute hepatitis CHuman immunodeficiency virus [HIV] diseaseIRCT20180924041107N1Tabriz University of Medical Sciences22
已完成
不适用
Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancercolorectal cancerJPRN-UMIN000001547Tsukuba Cancer Clinical Trial Group400